FindTrial
Sign In

A Prognostic Model Study of IgA Nephropathy Based on Clinicopathologic Features

A Prognostic Model Study of IgA Nephropathy Based on Clinicopathologic Features

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-16009120
Enrollment
Unknown
Registered
2016-08-30
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA Nephropathy

Interventions

Corhort:NA

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Biopsy-proven IgA nephropathy; 2. Aged 18-65 years old; 3. Followed up more than 2 years after biopsy.

Exclusion criteria

Exclusion criteria: 1. Systemic diseases like systemic lupus erythematosus, Henoch-Schnlein purpura, chronic liver disease etc.; 2. Critical missing of clinicopathologic, treatment data; 3. Lack of following up data.

Design outcomes

Primary

MeasureTime frame
End Stage of Renal Disease;Death;Dialysis;Double of serum creatinine;—

Countries

China

Contacts

Public ContactChuan Zou

Guangdong Provincial Hospital of Chinese Medicine

doctorzc541888@126.com+86 13570510358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026